HCID 58243400, compound → HCID 58243433, compound
Reaction equation
[CH3:1][CH:2]([N:4]1[CH2:10][CH2:9][CH2:8][N:7]([C:11]([N:13]2[CH2:16][CH:15]([OH:17])[CH2:14]2)=[O:12])[CH2:6][CH2:5]1)[CH3:3].F[C:19]1[CH:20]=[CH:21][C:22]([C:25]([OH:28])([CH3:27])[CH3:26])=[N:23][CH:24]=1>>[CH3:3][CH:2]([N:4]1[CH2:10][CH2:9][CH2:8][N:7]([C:11]([N:13]2[CH2:16][CH:15]([O:17][C:19]3[CH:20]=[CH:21][C:22]([C:25]([OH:28])([CH3:27])[CH3:26])=[N:23][CH:24]=3)[CH2:14]2)=[O:12])[CH2:6][CH2:5]1)[CH3:1]Participants
3
Procedure
In a similar fashion (Route 20, GP I), 1-{[4-(1-methylethyl)-1,4-diazepan-1-yl]carbonyl}azetidin-3-ol (100 mg, 0.41 mmol) and 2-(5-fluoropyridin-2-yl)propan-2-ol (90 mg, 0.41 mmol) were used to give the title compound. Crude material (50 mg) after workup gave the title compound as colourless oil (17.7 mg) after purification by preparative HPLC.
Sources & evidence
- ORD record
- ord-f4b5e8daa5754155b62f02c4d3efcccd
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691804B2
Reaction notes
Loading…